MX365635B - Combinacion terapeutica para el tratamiento de cancer. - Google Patents

Combinacion terapeutica para el tratamiento de cancer.

Info

Publication number
MX365635B
MX365635B MX2014004527A MX2014004527A MX365635B MX 365635 B MX365635 B MX 365635B MX 2014004527 A MX2014004527 A MX 2014004527A MX 2014004527 A MX2014004527 A MX 2014004527A MX 365635 B MX365635 B MX 365635B
Authority
MX
Mexico
Prior art keywords
cancer
treatment
therapeutic combination
combinations
nerium
Prior art date
Application number
MX2014004527A
Other languages
English (en)
Other versions
MX2014004527A (es
Inventor
R Knocke Dennis
B Nester Joseph
Papasotiriou Ioannis
Original Assignee
Nerium Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nerium Biotechnology Inc filed Critical Nerium Biotechnology Inc
Publication of MX2014004527A publication Critical patent/MX2014004527A/es
Publication of MX365635B publication Critical patent/MX365635B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Esta invención se relaciona a combinaciones terapéuticas que comprenden un agente antineoplástico a base de platino, como cisplatino y un extracto de especies del género Nerium oleander, así como también métodos de uso de las combinaciones para tratar sujetos, incluyendo humanos, que sufren de ciertos cánceres, como cáncer de próstata, melanoma, cáncer pancreático, cáncer pulmonar, cáncer de mama o cáncer colorrectal.
MX2014004527A 2011-10-20 2012-10-20 Combinacion terapeutica para el tratamiento de cancer. MX365635B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161549386P 2011-10-20 2011-10-20
PCT/US2012/061226 WO2013059753A1 (en) 2011-10-20 2012-10-20 Therapeutic combination for the treatment of cancer

Publications (2)

Publication Number Publication Date
MX2014004527A MX2014004527A (es) 2014-09-15
MX365635B true MX365635B (es) 2019-06-10

Family

ID=48141445

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2014004527A MX365635B (es) 2011-10-20 2012-10-20 Combinacion terapeutica para el tratamiento de cancer.
MX2019006685A MX2019006685A (es) 2011-10-20 2014-04-14 Combinacion terapeutica para el tratamiento de cancer.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2019006685A MX2019006685A (es) 2011-10-20 2014-04-14 Combinacion terapeutica para el tratamiento de cancer.

Country Status (13)

Country Link
US (2) US20130209579A1 (es)
EP (2) EP3711754A1 (es)
JP (1) JP6255346B2 (es)
CN (2) CN104093405A (es)
AU (3) AU2012325819B2 (es)
BR (1) BR112014009421A2 (es)
CA (1) CA2852274C (es)
GT (1) GT201400071A (es)
IL (2) IL231987B (es)
IN (1) IN2014KN00796A (es)
MX (2) MX365635B (es)
RU (2) RU2017136415A (es)
WO (1) WO2013059753A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102186487B (zh) * 2008-10-14 2013-05-15 奈瑞姆生物技术公司 提取强心苷的方法和组合物
AU2016250616B2 (en) * 2015-04-22 2021-01-21 Syn-Nat Products Enterprise LLC Co-crystal composition and its pharmaceutical use
KR20180063075A (ko) * 2015-10-05 2018-06-11 뉴카나 피엘씨 조합 요법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK239687A (da) 1986-05-13 1987-11-14 Huseyin Ziya Ozel Planteekstrakter
CA2354037A1 (en) 1998-09-24 2000-03-30 Ozelle Pharmaceuticals, Inc. Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof
US7407675B2 (en) * 2002-12-27 2008-08-05 The Trustees Of Columbia University In The City Of New York Anti-neoplastic compositions comprising extracts of black cohosh
US20060205679A1 (en) * 2004-10-22 2006-09-14 Azaya Therapeutics, Inc. Topical and oral formulations of cardiac glycosides for treating skin diseases
US7402325B2 (en) 2005-07-28 2008-07-22 Phoenix Biotechnology, Inc. Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander
EP1803461A1 (en) * 2005-12-27 2007-07-04 Heinz-Herbert Fiebig Therapeutic use of an extract from the leaves of Nerium oleander
DK2173337T3 (da) 2007-08-06 2014-09-15 Univ Ohio Phosphaplatiner og deres anvendelse i behandlingen af cancer, der er resistent over for cisplatin og carboplatin
CN102186487B (zh) * 2008-10-14 2013-05-15 奈瑞姆生物技术公司 提取强心苷的方法和组合物

Also Published As

Publication number Publication date
WO2013059753A1 (en) 2013-04-25
AU2012325819B2 (en) 2017-08-03
CN110269940A (zh) 2019-09-24
JP6255346B2 (ja) 2017-12-27
IN2014KN00796A (es) 2015-10-02
NZ623550A (en) 2016-06-24
CA2852274C (en) 2019-08-06
JP2014530878A (ja) 2014-11-20
IL231987B (en) 2020-07-30
EP2768498B1 (en) 2020-03-04
CN104093405A (zh) 2014-10-08
AU2019203577A1 (en) 2019-06-13
BR112014009421A2 (pt) 2017-04-18
IL275636A (en) 2020-08-31
RU2014120179A (ru) 2015-11-27
EP3711754A1 (en) 2020-09-23
MX2019006685A (es) 2019-08-21
US20130209579A1 (en) 2013-08-15
EP2768498A1 (en) 2014-08-27
RU2017136415A3 (es) 2021-02-08
AU2017254875A1 (en) 2017-11-23
GT201400071A (es) 2015-09-17
CA2852274A1 (en) 2013-04-25
RU2017136415A (ru) 2019-02-08
US20190343908A1 (en) 2019-11-14
AU2012325819A1 (en) 2014-04-24
IL231987A0 (en) 2014-05-28
EP2768498A4 (en) 2015-06-17
MX2014004527A (es) 2014-09-15

Similar Documents

Publication Publication Date Title
MX2022001718A (es) Combinaciones de cabozantinib y atezolizumab para tratar cancer.
MX360404B (es) Compuestos para inhibir la proliferacion celular en canceres transmitidos por egfr.
PH12015501744B1 (en) Therapeutic and diagnostic target for cancer comprising dll3 binding reagents
NZ746554A (en) Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
PH12017502086A1 (en) Cancer treatments
MX2018008426A (es) Combinaciones anti-egfr para tratar tumores.
SA515360657B1 (ar) مثبطات ديميثيلاز هيستون
MX2018008427A (es) Combinaciones anti-cd20 para tratar tumores.
MX2019006331A (es) Métodos para tratar el cáncer usando anticuerpos anti-pd-l1 y antiandrógenos.
MX2015007185A (es) Uso de eribulina en el tratamiento de cancer de pecho.
AU2014358850A8 (en) Estrogen receptor modulator for the treatment of locally advanced or metastatic estrogen receptor positive breast cancer
MX2012003851A (es) Tratamiento de cánceres resistentes antagonistas notch1, mediante el uso de antagonistas notch3.
UA109271C2 (uk) Комбінація фітоканабіноїдів та темозоламіду для лікування гліоми
MX366804B (es) Translocaciones de la r-espondina y sus metodos de uso.
MX2015014046A (es) Combinaciones de farmacos para tratar cancer.
NZ725595A (en) Compounds for treating brain cancer
MX2013008750A (es) Analogos de estilbeno y metodos para tratar cancer.
MX2013006140A (es) Uso de ligandos sigma en dolor por cancer de huesos.
MX2013002155A (es) Compuestos para el tratamiento de cancer.
CR20110479A (es) Combinaciones farmaceuticas que comprenden rdea 119/bay 869766 para el tratamiento de canceres especificos
MX2019006685A (es) Combinacion terapeutica para el tratamiento de cancer.
MX2018013815A (es) Metodos y materiales para estadificar y tratar cancer de piel.
MX2021002884A (es) Terapia de combinacion para el tratamiento de cancer de prostata.
MX2017013666A (es) Terapia de combinacion de agente anti-fuctactico y agente de inmunoterapia y composiciones para el tratamiento de cancer.
BR112019025164A2 (pt) Esquema de dosagem para tesetaxel e capecitabina

Legal Events

Date Code Title Description
FG Grant or registration